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Perception of pain in the minimally conscious state 
with PET activation: an observational study
Mélanie Boly, Marie-Elisabeth Faymonville, Caroline Schnakers, Philippe Peigneux, Bernard Lambermont, Christophe Phillips, 
Patrizio Lancellotti, Andre Luxen, Maurice Lamy, Gustave Moonen, Pierre Maquet, Steven Laureys
Summary
Background Patients in a minimally conscious state (MCS) show restricted self or environment awareness but are 
unable to communicate consistently and reliably. Therefore, better understanding of cerebral noxious processing in 
these patients is of clinical, therapeutic, and ethical relevance. 
Methods We studied brain activation induced by bilateral electrical stimulation of the median nerve in ﬁ ve patients in 
MCS (aged 18–74 years) compared with 15 controls (19 –64 years) and 15 patients (19–75 years) in a persistent vegetative 
state (PVS) with 15O-radiolabelled water PET. By way of psychophysiological interaction analysis, we also investigated 
the functional connectivity of the primary somatosensory cortex (S1) in patients and controls. Patients in MCS were 
scanned 57 (SD 33) days after admission, and patients in PVS 36 (9) days after admission. Stimulation intensities 
were 8·6 (SD 6·7) mA in patients in MCS, 7·4 (5·9) mA in controls, and 14·2 (8·7) mA in patients in PVS. Signiﬁ cant 
results were thresholded at p values of less than 0·05 and corrected for multiple comparisons.
Findings In patients in MCS and in controls, noxious stimulation activated the thalamus, S1, and the secondary 
somatosensory or insular, frontoparietal, and anterior cingulate cortices (known as the pain matrix). No area was less 
activated in the patients in MCS than in the controls. All areas of the cortical pain matrix showed greater activation in 
patients in MCS than in those in PVS. Finally, in contrast with patients in PVS, those in MCS had preserved functional 
connectivity between S1 and a widespread cortical network that includes the frontoparietal associative cortices.
Interpretation Cerebral correlates of pain processing are found in a similar network in controls and patients in MCS 
but are much more widespread than in patients in PVS. These ﬁ ndings might be objective evidence of a potential 
pain perception capacity in patients in MCS, which supports the idea that these patients need analgesic treatment. 
Funding FNRS; Reine Elisabeth Medical Foundation; University of Liège; European Commission; James S McDonnell 
Foundation; Mind Science Foundation; Concerted Research Action; Fondation Léon Frédéricq.
Introduction
A persistent vegetative state (PVS) is deﬁ ned by 
wakefulness without awareness of self or the 
environment,1 whereas patients in a minimally 
conscious state (MCS) show some evidence of self and 
environmental awareness.2 However, the carers of 
patients who are minimally conscious have diﬃ  culties 
in assessing the patients’ level of conscious pain 
perception through their behaviour. Moreover, there are 
no guidelines on pain treatment in patients in MCS.3 
Noxious stimulation is a routine clinical procedure for 
the bedside assessment of consciousness in patients 
who are severely brain damaged. Noxious stimulation 
is also part of the commonly used coma scales, such as 
the Glasgow coma scale (GCS),4 the reaction level scale,5 
the Innsbruck coma scale,6 the Edinburgh 2 coma scale,7 
and the coma recovery scale.8 The study of cerebral 
processing of noxious stimulation in these patients is 
also of clinical, therapeutic, and ethical relevance.9 We 
have previously reported on the cortical responses of 
patients in PVS to similar noxious somatosensory 
stimuli by use of ¹⁵O-radiolabelled water PET,10 and 
found that the only areas that signiﬁ cantly responded to 
noxious stimulation in patients in PVS were the 
brainstem, contralateral thalamus, and primary 
somatosensory cortex (S1). Here, we used an identical 
set-up to study ﬁ ve patients who are in MCS and 
compared the results with those from patients in PVS 
and 15 healthy controls. 
Methods
Participants
Five non-sedated patients in MCS (4 men; mean age 
49 [SD 22] years, range 18–74 years), 15 non-sedated 
patients in PVS (12 men; mean age 48 [17] years, range 
19–75 years), and 15 healthy volunteers (8 male; mean 
age 40 [9] years, range 19–64 years) were studied 
prospectively. Table 1 shows the demographic data of the 
patients in MCS. The aetiologies of the patients in PVS 
were: cardiorespiratory arrest (n=5), diﬀ use axonal injury 
(n=3), drugs overdose (n=2), prolonged respiratory 
insuﬃ  ciency (n=2), encephalitis with diﬀ use white 
matter lesions (n=2), and carbon monoxide intoxication 
(n=1). Clinical diagnoses were made on the basis of 
repeated, standardised evaluation11 and conformed to 
international criteria for PVS12 and MCS.13 Patients were 
assessed four times by trained and experienced assessors 
(SL and CS): 1 week and 1 day before scanning, the day of 
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the scan, and 1 week after the scan. None of the patients 
in MCS showed localisation in response to noxious 
stimuli and none of the patients in PVS showed normal 
ﬂ exion or withdrawal in response to noxious stimuli. 
Mean GCS4 on admission were 6 (SD 5) points for the 
patients who were minimally conscious and 5 (3) points 
for the patients in PVS. All patients had preserved 
pupillary, corneal, and vestibulo-ocular reﬂ exes. 
Assessment of median nerve sensory conduction velocity 
and somatosensory evoked potential excluded peripheral 
nerve, plexus, or spinal cord lesions. Short latency 
auditory evoked potentials showed preserved pontine 
and midbrain functions in all patients.
Procedures
Patients in MCS were scanned a mean of 57 (SD 33) days 
after admission and patients in PVS 36 (9) days after 
admission. Patients were scanned during awake periods, 
as shown by simultaneous polygraphic recordings 
(electroencephalogram and electro-oculogram). Through-
out the procedure, patients were monitored by a senior 
anaesthetist (MEF), assisted by an intensive care 
physician. Written, informed consent was obtained from 
the people with legal responsibility for the patients and 
from all controls personally. Stimulation was kept at the 
minimum duration (6×70 s) and minimum intensity 
needed for PET. Stimulation intensities were increased to 
the point where all components of the somatosensory 
evoked potentials showed maximum amplitude;14 the 
stimulation intensity was then kept constant throughout 
the experiment. Electrical stimulation of the median 
nerve at the intensity used was rated as highly unpleasant 
to painful by the controls.10 Stimulation intensity was not 
signiﬁ cantly diﬀ erent for the patients in MCS than for 
patients in PVS or controls (MCS mean 8·6 [SD 6·7] mA; 
PVS mean 14·2 [8·7] mA; controls mean 7·4 [5·9] mA). 
Patient 1 Patient 2 Patient 3* Patient 4 Patient 5*
Sex Male Female Male Male Male
Age (years) 41 64 74 18 50
Cause Cardiorespiratory arrest Respiratory arrest and 
hypotension
Encephalitis Traumatic posterior fossa 
haematoma
Diﬀ use axonal injury 
Glasgow coma score on admission 3 points 3 points 14 points 6 points 6 points
Time from admission to PET 41 days 116 days 40 days 50 days 37 days
Outcome at 12 months Distinctly dependent Distinctly dependent Died Moderately dependent Distinctly dependent
Clinical evaluation at time of PET
Interactive communication Absent Absent Absent Absent Absent
Functional use of ≥2 objects Absent Absent Absent Absent Absent
Best verbal response None Incomprehensible sounds None None Incomprehensible sounds
Best gestural response Smiles in response to 
relevant visual stimuli
Inconsistent tongue protrusion 
to auditory command
Smiles in response to 
relevant verbal stimuli
Inconsistent movement of left 
foot to auditory command
Tongue protrusion
Best motor response to 
noxious stimuli
Flexion withdrawal Stereotyped extension 
posturing
Stereotyped ﬂ exion 
posturing
Flexion withdrawal Stereotyped extension 
posturing
Eye opening Spontaneous Spontaneous Spontaneous Spontaneous Spontaneous
Sleep–wake cycles Present Present Present Present Present
Arousal level Fluctuates Healthy Healthy Fluctuates Fluctuates
Eye movements Fixation on family members Tracking Tracking of family 
members
Tracking Inconsistent tracking and 
ﬁ xation
Eye blinking to visual threat Present Present Present Present Present
Breathing Healthy Healthy Healthy Healthy Healthy
Gag reﬂ ex Present Present Present Present Present
Deep tendon reﬂ exes Raised Raised Raised Raised Raised
Skeletal muscle tone Spastic Spastic Spastic Spastic Spastic
Paralysis or paresis Bilateral Bilateral Bilateral Bilateral Bilateral
Babinski’s sign Bilateral Absent Absent Bilateral Absent
EEG
Background activity Disorganised delta waves Reactive and disorganised 
theta waves




Increased intensity on 
T2-weighted MRI
Periventricular Diﬀ use white matter  and 
cortical atrophy
Diﬀ use white matter Intracerebellar, left occipital, 
and bifrontal contusions
Diﬀ use white matter
*Previously reported.1
Table 1: Clinical, electrophysiological, and structural imaging data of patients in MCS
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The stimulation intensities used in non-communicative 
patients were lower than those used routinely when 
somatosensory evoked potentials are recorded at an 
intensive care unit.15
The study was approved by the ethics committee of the 
Faculty of Medicine of the University of Liège and done 
in accordance with the Declaration of Helsinki16 and the 
International Association for the Study of Pain (IASP) 
Ethical Guidelines for Pain Research in Humans.17
Changes in regional cerebral blood ﬂ ow were 
measured with ¹⁵O-radiolabelled water PET, as described 
elsewhere.10 Data acquisition in patients in MCS started 
24 months after the study in patients in PVS.10 Scans 
were done during rest and electrical stimulation of the 
left-sided and right-sided median nerve (0·2 ms square-
wave pulses at 5·1 Hz at the wrist). We chose bilateral 
median nerve stimulation because this meant that both 
hemispheres were recruited in patients with severe 
brain injury. The conditions of each test were repeated 
three times (except in one patient, in whom only two 
scans could be obtained for left-sided and two scans for 
right-sided noxious stimulation). The order or 
presentation was pseudorandomised for all patients. 
Haemodynamic parameters were monitored, and 
Region (Brodmann area) Side x y z  z value Corrected p value
Controls
Activations Thalamus Contralateral –10 –10 8 4·50 0·0001
Ipsilateral 6 –6 8 3·85 0·001
Primary somatosensory cortex Contralateral –48 –28 58 5·42 <0·0001
Secondary sensory cortex/insula Contralateral –38 –22 12 7·42 <0·0001
Inferior parietal lobule (39/40) Contralateral –64 –34 36 4·70 <0·0001
Ipsilateral 66 –42 34 3·34 0·007
Inferior parietal lobule (7/40) Contralateral –50 –66 44 2·82 0·023
Ipsilateral 48 –66 46 2·90 0·020
Superior temporal gyrus (22/42) Contralateral –62 –34 20 5·97 <0·0001
Ipsilateral 66 –34 24 4·19 0·0004
Striatum Contralateral –26 –10 0 5·04 <0·0001
Ipsilateral 22 16 2 4·28 0·0003
Anterior cingulate cortex (24/32) Medial 2 20 36 5·10 <0·0001
Posterior cingulate cortex (23) Medial –4 –20 32 4·76 <0·0001
DLPFC (9/10) Contralateral –32 52 26 3·16 0·010
Ipsilateral 44 50 –6 2·60 0·039
Deactivations Posterior cingulate or precuneus Medial 10 –54 62 3·58 0·002
Medial prefrontal cortex Medial –2 52 26 2·77 0·019
Parietal cortex Ipsilateral 24 –36 54 4·61 <0·0001
Occipital cortex Ipsilateral 6 –76 8 6·17 <0·0001
Patients in MCS
Activations Thalamus Contralateral –14 –10 14 3·27 0·019*
Primary somatosensory cortex Contralateral –46 –26 54 4·40 0·008
Secondary sensory cortex or insula Contralateral –34 –24 26 4·93 0·007
Inferior parietal lobule (39/40) Contralateral –64 –38 28 3·14 0·016*
Inferior parietal lobule (7/40) Contralateral –36 –32 44 4·75 0·007
Superior temporal gyrus (22/42) Contralateral –66 –42 20 3·16 0·016*
Anterior cingulate cortex (24/32) Medial 12 10 36 3·21 0·038*
DLPFC (9/10) Contralateral –38 48 30 3·48 0·045*
Deactivations Posterior cingulate or precuneus Medial –6 –56 20 3·07 0·001†
Medial prefrontal cortex Medial 0 50 –18 2·67 0·004*
Diﬀ erences in stimulation-induced regional cerebral blood ﬂ ow changes
Activations No areas identiﬁ ed
Deactivations Posterior cingulate or precuneus Medial 2 –54 62 4·21 0·009
Occipital cortex Contralateral –18 –78 18 4·42 0·009
*Results are thresholded at p values <0·05 corrected for multiple comparisons with FDR at the whole brain level or in a 10 mm radius sphere around predetermined 
coordinates from healthy controls. †Uncorrected p values (these areas did not reach signiﬁ cance when corrected for multiple comparisons). DLPFC=dorsolateral prefrontal 
cortex.
Table 2: Peak voxels for signiﬁ cant changes in regional cerebral blood ﬂ ow in response to noxious stimulation
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electroencephalogram, electromyogram, ocular move-
ments, and somatosensory evoked potentials were 
recorded throughout the procedure. A high-resolution, 
T1-weighted brain MRI was obtained for coregistration 
to the functional data.
Statistical analysis
PET data were realigned, spatially normalised, smoothed, 
and analysed with statistical parametric mapping. 
Because SPM is a more powerful voxel-based statistical 
method with more precise anatomical validity, it was 
preferred over the region-of-interest approach. A 
smoothing kernel of full width at a half maximum of 
16 mm was chosen owing to the severely damaged brains 
of the patients in MCS or PVS. The smoothing was 
identical to that used in our previous study.10 Data 
obtained during left-sided noxious stimulation and at 
rest were ﬂ ipped, as reported previously.10 A random 
eﬀ ects analysis18 identiﬁ ed the areas of the brain that 
were activated during noxious stimulation. We calculated 
one contrast between stimulation and rest per patient, 
which accounts for the within-patient component of the 
variance. We used these contrast images in a second 
design matrix that took into account the between-patient 
component of the variance and separated the data into 
three groups (controls, patients in PVS, and patients in 
MCS). The ﬁ rst two contrasts searched for brain activation 
in response to noxious stimulation in controls and 
patients in an MCS. We also looked for the group 
interaction ([controls–patients in MCS] × condition 
[stimulation–rest]) to search for areas that were less 
activated in patients in MCS than in healthy controls.19 A 
second group interaction was done ([patients in 
MCS–patients in VS]×condition [stimulation–rest]) to 
search for the areas that were more activated in patients 
in MCS than patients in PVS. By use of reversed 
T contrasts we also looked for and compared deactivations 
during noxious processing with baseline in controls and 
patients in MCS. The results from the patients were 
masked inclusively by the results from the controls 
(uncorrected p<0·05). The results from controls and 
comparisons between patient populations were 
thresholded at a whole-brain false discovery rate (FDR)-
corrected p value of less than 0·05.20,21 Results from 
patients in MCS were thresholded at p values less than 
0·05 and corrected for multiple comparisons with FDR 
at the whole-brain level or in a small volume (spheres 
with 10 mm radii) centred on the peak voxels of interest 
that were identiﬁ ed in controls.
Finally, we did a psychophysiological analysis, as 
previously described.10 Our previous analysis was of the 
modulation between S1 and the rest of the brain in 
controls and patients. The ﬁ rst analysis looked for 
preserved modulation between S1 and the rest of the 
brain in patients in MCS compared with controls, by way 
of a conjunction approach—a conjunction analysis 
requires that all tested comparisons are individually 
signiﬁ cant.22 Here, we looked for brain regions that were 
signiﬁ cantly modulated by S1 in patients in MCS and 
controls. A second analysis looked for diﬀ erences 
between patients in MCS and controls. Finally, we 
searched for diﬀ erences of S1 functional connectivity 
between patients in MCS or patients in PVS. Results 































Figure: Brain activation to pain in controls and patients in MCS
(Top) Regions of the brain that were activated during noxious stimulation in controls (stimulation–rest). (Bottom) Brain regions commonly activated during 
stimulation in patients in MCS and in controls. Signiﬁ cant results were thresholded for display at uncorrected p value <0·001 and projected on sagittal (x=4 mm), 
coronal (y=–24 mm), and transverse (z=42 mm) sections of a normalised brain MRI template in controls and on the mean MRI of the patients (distances are relative 
to the bicommisural plane). T=thalamus. PCC=posterior cingulate cortex. ACC=anterior cingulate cortex. S2/INS=secondary somatosensory cortex or insula. 
S1=primary somatosensory cortex.
For more on statistical 
parametric mapping (SPM) see 
www.ﬁ l.ion.ucl.ac.uk/spm
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p<0·05). All results from psycho-physiological 
interactions were thresholded at a whole-brain FDR-
corrected p value of less than 0·05.
Role of the funding source
The funding sources had no role in the study design, 
data collection, data analysis, data interpretation, or 
writing of this report. All authors had full access to all the 
data in the study and had ﬁ nal responsibility for the 
decision to submit for publication.
Results
In the controls, noxious stimulation resulted in the 
subjective experience of pain and increased regional 
cerebral blood ﬂ ow in several areas, including the 
thalamus, striatum, contralateral S1, secondary 
somatosensory or insular cortices, superior temporal, 
posterior, parietal, posterior cingulate, prefrontal, and 
anterior cingulate cortices (table 2 and ﬁ gure). Compared 
with baseline, deactivations could also be found in the 
posterior cingulate and precuneus and medial prefrontal 
cortices (table 2).
Patients who were minimally conscious also showed 
signiﬁ cant activation in all the areas activated in the 
controls (table 2, webﬁ gure), although the pattern of 
activation was lateralised and with less spatial extent. The 
total extent of stimulus-induced cerebral activation (at an 
uncorrected p value of <0·001) in controls and patients in 
MCS was 4395 and 1471 voxels, respectively, taking into 
account the diﬀ erences in the numbers of patients. 
However, the interaction analysis did not identify any 
voxel that was signiﬁ cantly less activated in the patients 
in MCS compared with controls. During noxious 
stimulation, the posterior cingulate or precuneus and 
medial prefrontal cortices also showed deactivation in 
patients in MCS, but there was no diﬀ erence in 
deactivation after correction for multiple comparisons. 
However, deactivations in patients in MCS were 
signiﬁ cantly less pronounced than in controls (table 2).
Compared with patients in PVS, patients who were 
minimally conscious showed signiﬁ cantly greater 
activation in the S1, secondary somatosensory cortex or 
insula, anterior cingulate cortex, and posterior parietal 
and dorsolateral prefrontal cortices (table 3). No voxels 
were signiﬁ cantly less activated in patients in MCS 
compared with patients in PVS. 
Finally, psychophysiological interaction analysis 
revealed preserved modulation between S1 and a large 
set of associative areas, including the high order 
frontoparietal cortices, in patients in MCS (table 4). 
Compared with controls, patients in MCS had impaired 
connectivity in the posterior cingulate or precuneus and 
in the medial prefrontal cortices. When patients in MCS 
were compared with patients in PVS, functional 
connectivity between the S1 and the lateral and medial 
frontoparietal areas was signiﬁ cantly higher in patients 
in MCS than those in PVS.
Discussion
Pain is a subjective experience.23 By deﬁ nition, patients in 
MCS are unable to consistently and reliably communicate 
their experiences, and their behavioural responses to 
noxious stimulation are often diﬃ  cult to interpret. Even if 
some patients in MCS can correctly answer yes or no 
questions at a level above chance, a question such as, “Are 
you in pain?” might not elicit a reliable response. The 
behavioural assessment of motor or autonomic signs (ie, 
respiratory frequency, heart rate, blood pressure, pupillary 
diameter, and skin conductance) are not reliable markers 
of the conscious perception of pain, as shown in studies 
done in general anaesthesia.24 The evaluation and 
treatment of pain is therefore an important clinical and 
ethical problem in patients in MCS. In this context, 
functional neuroimaging can objectively measure changes 
in brain function during noxious stimulation in these 
patients. Indeed, several authors have stressed the need 
for brain imaging studies of pain processing in patients 
who are in altered states of consciousness.12,25–27 The study 
of cerebral responses to painful stimuli in patients with 
altered states of consciousness can also help to understand 
pain processing in healthy patients.28
Side x y z z value Corrected p value
Primary somatosensory cortex Contralateral –36 –28 34 4·18 0·019
Secondary sensory cortex/insula Contralateral –38 –22 22 4·14 0·019
Inferior parietal lobule (39/40) Contralateral –44 –32 32 4·00 0·023
Inferior parietal lobule (7/40) Contralateral –36 –34 42 5·07 0·013
Superior temporal gyrus (41) Contralateral –42 –30 6 3·10 0·046
Anterior cingulate cortex (24) Medial 12 8 40 3·02 0·050
DLPFC (9/10) Contralateral –38 46 32 3·66 0·030
All results are thresholded at a whole-brain FDR-corrected p value <0·05. Figures in brackets are Brodmann areas. 
DLPFC=dorsolateral prefrontal cortex. Data from patients in PVS has been published previously.10 
Table 3: Peak areas that show greater activation in response to noxious stimulation in patients in MCS 
compared with patients in PVS
Side x y z z value Corrected p value
Patients in MCS and controls
Secondary sensory cortex/insula Contralateral –38 –34 22 4.36 0·0001
Posterior parietal cortex (40) Contralateral –62 –16 22 6·07 <0·0001
Premotor cortex (6) Contralateral –56 2 34 4·98 <0·0001
DLPFC (9/10) Contralateral –40 52 20 3·34 0·004
Superior temporal cortex (22) Contralateral –50 –38 0 6·80 <0·0001
Patients in MCS<controls
Posterior cingulate or precuneus Medial 6 –68 50 3·81 0·0003
Medial prefrontal cortex Medial 6 66 20 3·74 0·0003
Occipital cortex Ipsilateral 26 –72 8 Inf <0·0001
All results are thresholded at whole-brain FDR-corrected p value <0·05. Areas are signiﬁ cantly more connected to S1 
during noxious processing in patients in MCS compared with patients in PVS. Figures in brackets are Brodmann area. 
DLPFC=dorsolateral prefrontal cortex.
Table 4: Areas that show preserved functional connectivity in patients in MCS and controls and in 
patients  in MCS compared with patients in PVS
See Online for webﬁ gure
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The role of diﬀ erent areas of the brain in pain 
processing is only partially understood, and the neural 
representation of the brain is thought to be both speciﬁ c 
and integrated. In summary, the sensory-discriminative 
component of pain is thought to depend on primary and 
secondary somatosensory cortices, and the aﬀ ective-
motivational on the anterior cingulate cortex and 
prefrontal areas—the insular cortex has an intermediate 
role.29–32 
In healthy volunteers, electrical stimulation of the 
median nerve was perceived as highly unpleasant to 
painful and activated areas of the brain that were 
previously described in pain imaging studies—the pain 
matrix.30,31,33 A similar set of cortical and subcortical areas 
was activated during noxious stimulation in patients in 
MCS and in healthy controls. The only areas that were 
not signiﬁ cantly activated in patients in MCS were the 
posterior cingulate cortex and the striatum, but direct 
comparison of the activation of these areas between 
controls and patients in MCS did not show a signiﬁ cant 
diﬀ erence. We cannot exclude the possibility that there is 
a diﬀ erence in the cerebral processing of painful stimuli 
between patients in MCS and controls because the 
activation volumes were greater and more bilateral in 
controls than in patients in MCS; however, this might 
also be because of the few patients in MCS who were 
scanned. Finally, when patients in MCS were compared 
with controls no area was signiﬁ cantly less activated, 
whereas the activation of a large number of associative 
areas during noxious stimulation was not seen in any of 
the patients in PVS.10 Indeed, the patients in MCS not 
only had activation in the contralateral thalamus and S1, 
as did the patients in PVS, but also in high-order 
associative areas, including contralateral secondary 
somatosensory and posterior insular cortices, posterior 
parietal and dorsolateral prefrontal cortices, and anterior 
cingulate cortex. The whole cortical pain matrix was 
signiﬁ cantly more activated in patients in MCS than in 
patients in PVS when both populations were compared 
directly. In patients in MCS, functional connectivity 
between the primary somatosensory cortices and lateral 
frontoparietal cortices was similar to the functional 
connectivity in the controls. This frontoparietal network 
connectivity was signiﬁ cantly stronger in patients in 
MCS than in patients in PVS. These ﬁ ndings indicate 
that patients in MCS might show an elaborate and 
integrated level of noxious processing, which contrasts 
with previous ﬁ ndings in patients in PVS.10 The time 
lapse between the study in patients in PVS and the 
current study in patients in MCS makes unbiased 
comparisons diﬃ  cult. However, the infrastructure 
(scanner, scanning protocol, and painful stimulation 
methodology) was matched for both studies.
Peak pain-related activation was found in the secondary 
somatosensory or posterior insular cortex in patients in 
MCS and in controls. The insular cortex is thought to be 
important for pain perception because it was activated in 
brain imaging studies on pain,31,34 and direct electrical 
stimulation of the insular cortex induces the sensation of 
pain in human beings.35 However, a recent PET study 
showed activation of the insular cortex during general 
anaesthesia in healthy volunteers;36 the authors 
interpreted these results as brain autonomic responses 
evoked by the noxious stimulation. In patients in MCS, 
however, activation of the insular cortex in response to 
noxious stimulation was associated with brain activity 
and functional connectivity in several brain areas that are 
involved in both the sensory and limbic aspects of pain 
processing.29–31 More speciﬁ cally, the activation of high-
order frontoparietal cortices has been repeatedly 
associated with the conscious perception of external 
stimuli in visual37,38 and somatosensory28,39 modalities. 
Even if the neural correlates of conscious perception and 
pain processing need to be fully elucidated,40 the 
coactivation of specialised sensory cortices and 
frontoparietal areas seems both necessary and suﬃ  cient 
to generate conscious perception.41 Although brain 
imaging is not a shortcut to subjectivity, we interpret the 
brain activation and functional connectivity patterns seen 
in patients in MCS as likely to show conscious perception 
of noxious stimuli. 
Among the commonly identiﬁ ed cerebral areas in 
human neuroimaging studies, the anterior cingulate and 
insular cortices show particularly consistent responses 
during the pain.42 Moreover, the level of activation in the 
anterior cingulate cortex correlates with pain intensity 
scores.30,42 In brain imaging studies, activation of the 
anterior cingulate cortex was associated with the aﬀ ective-
motivational components of pain perception,43 and in the 
processing of stimulus intensity44 and stimulus 
awareness.28,44 The activation of the anterior cingulate 
cortex in response to noxious stimuli in patients in MCS 
is important because it suggests that they might also 
have pain aﬀ ect. The impaired deactivation and functional 
connectivity seen in areas of the default network (ie, the 
posterior cingulate or precuneus and medial prefrontal 
cortices),45 which are thought to be involved in self-related 
processes,46 could show preserved but diﬀ erent-from-
normal perception of pain in patients in MCS.3
We believe that these results should prompt the use of 
analgesics in patients in MCS, particularly when invasive 
surgery or other clinical procedures are necessary. 
Although pain is a ﬁ rst-person experience and the neural 
substrates of the conscious perception of pain are 
unknown, the extent of brain activation induced in 
patients in MCS in response to noxious stimulation, 
which was not diﬀ erent from that in controls, suggests 
that there is at least some level of pain sensory and 
aﬀ ective perception. In our study, patients in MCS did 
not have signiﬁ cantly less activation than did the controls. 
However, this negative ﬁ nding might be biased by 
reduced statistical power due to the small number of 
patients studied. This concern does not apply when 
comparing patients in MCS with those in PVS, in whom 
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signiﬁ cant diﬀ erences could be shown. We only did 
analyses at the group level; hence, our results do not 
imply that none of the patients in PVS could activate a 
large number of brain areas in response to noxious 
stimulation or that all patients in MCS do so—even if the 
random eﬀ ects analyses we used took within-patient  and 
between-patient variability into account. Unfortunately, 
the ¹⁵O-radiolabelled water PET technique does not 
enable us to identify reliably activation maps in individual 
patients. Functional MRI can tackle this problem because 
many more scans can be acquired per patient; these 
studies are currently ongoing. Our ﬁ ndings are relevant 
for the understanding of pain processing and to ethical 
discussions but do not provide suﬃ  cient evidence to 
guide the clinical management of individual patients. 
Variability in pain processing is expected between 
individuals in heterogeneous populations of patients. 
Although our study also stresses the need to distinguish 
at the bedside patients in MCS from patients in PVS, 
several studies have shown that misdiagnosis is common 
between these populations of patients.27 The evidence is 
not suﬃ  cient to choose not to treat potentially painful 
conditions in patients in PVS. Analgesic intervention in 
these patients is also desirable to prevent potentially 
damaging defensive hormonal reactions (eg, adrenal 
stress hormones), despite the possible absence of pain. 
Controlled trials that report objective outcomes, such as 
the absence of negative complications and survival, 
would enable assessment of the clinical appropriateness 
of analgesia in patients in PVS or MCS.
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